← FDA Drug Approvals (Drugs@FDA)
MICAFUNGIN SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: XELLIA PHARMS APS · Approved 2021-06-02
Drug application
- FDA Application #
ANDA211713- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- MICAFUNGIN SODIUM
- Generic name
- Micafungin Sodium
- Active ingredients
- MICAFUNGIN SODIUM
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- XELLIA PHARMS APS
- First approval
- 2021-06-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown